Helmholtz AI is a research-driven hub for applied artificial intelligence (AI) and one of five platforms initiated by the Helmholtz Information and Data Science Incubator. Three years after the foundation, Helmholtz AI underwent a review in October…
"A startup can be just as big a success as a Leibniz Prize!"
Matthias Tschöp, CEO of Helmholtz Munich, talks about translating scientific discoveries into clinical practice, about ambitious targets, and about ideas he acquired during his time in the USA.
Mass spectrometry imaging provides new insights into X-linked hypophosphatemia
The renal phosphate wasting disease X-linked hypophosphatemia (XLH) is a rare metabolic disorder of the bones associated with severe renal phosphate loss. The first symptoms of the genetic defect appear in childhood and adolescence and can…
Two MSCA Postdoctoral Fellowships Awarded to Researchers at Helmholtz Munich
Dr. Robert Frömel and Dr. Hossam Montaser have been awarded Marie Skłodowska Curie Postdoctoral Fellowships. Over a period of two years, the EU funded fellowships will support their independent research projects on gene regulation in brain…
Michael Witting Receives Metabolomics Society Medal 2026
Dr. Michael Witting has been awarded the Metabolomics Society Medal 2026. The international scientific society recognizes his contributions to the advancement and application of metabolomics methodologies. The medal was presented during the opening…
Dr. Steffen Schneider of Helmholtz Munich and KI macht Schule gGmbH has been admitted as a new member of the Young Academy. Working at the interface of artificial intelligence, neuroscience, and statistical modelling, Schneider joins the Academy's…
